Dr Phil Jones, Chief Scientific Officer at BioAscent delivered a talk at the Open Access to Drug Discovery event on 23rd November 2018 at the University of Cambridge.
The showcasing event provided insight to the vast array of open access opportunities available to researchers who are wishing to start or progress on a drug discovery pathway.
Dr Phil Jones from BioAscent gave a presentation on Compound Cloud, and the access to a compound library over 125,000 lead-like and drug-like compounds.
Other speakers from AstraZeneca, ChEMBL, EU OPENSCREEN, GSK, J&Ji and UCB also presented a range of topics including chemical databases and tools, compound screening services and antibody development opportunities which are available.
To listen to Phil's presentation, click on the video below.